Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.

Documenti analoghi

• Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy
  di: Cantrell, Leigh A., et al.
  Pubblicazione: (2009)
• Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis
  di: Shafer, Aaron, et al.
  Pubblicazione: (2010)
• Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways
  di: Malloy, Kim M, et al.
  Pubblicazione: (2018)
• Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
  di: Han, Jianjun, et al.
  Pubblicazione: (2015)
• Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice
  di: Matthew R. Grace, et al.
  Pubblicazione: (2019-04-01)